155 related articles for article (PubMed ID: 1872889)
1. N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans.
Hickman D; Sim E
Biochem Pharmacol; 1991 Aug; 42(5):1007-14. PubMed ID: 1872889
[TBL] [Abstract][Full Text] [Related]
2. Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants.
Hickman D; Risch A; Camilleri JP; Sim E
Pharmacogenetics; 1992 Oct; 2(5):217-26. PubMed ID: 1306121
[TBL] [Abstract][Full Text] [Related]
3. Arylamine N-acetyltransferase activity in human cultured cell lines.
Coroneos E; Sim E
Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):481-6. PubMed ID: 8396914
[TBL] [Abstract][Full Text] [Related]
4. [Detection of mutation in NAT II gene as a method of determination of izoniazyd (INH) acetylation type in human population].
Augustynowicz-Kopeć E; Zabost A; Kozińska M; Brzezińska S; Zwolska Z
Pneumonol Alergol Pol; 2007; 75(2):134-9. PubMed ID: 17973219
[TBL] [Abstract][Full Text] [Related]
5. A method for genotyping murine arylamine N-acetyltransferase type 2 (NAT2): a gene expressed in preimplantation embryonic stem cells encoding an enzyme acetylating the folate catabolite p-aminobenzoylglutamate.
Payton M; Smelt V; Upton A; Sim E
Biochem Pharmacol; 1999 Sep; 58(5):779-85. PubMed ID: 10449187
[TBL] [Abstract][Full Text] [Related]
6. Molecular and genetic analyses of arylamine N-acetyltransferase polymorphism of rabbit liver.
Sasaki Y; Ohsako S; Deguchi T
J Biol Chem; 1991 Jul; 266(20):13243-50. PubMed ID: 2071601
[TBL] [Abstract][Full Text] [Related]
7. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans.
Bell DA; Taylor JA; Butler MA; Stephens EA; Wiest J; Brubaker LH; Kadlubar FF; Lucier GW
Carcinogenesis; 1993 Aug; 14(8):1689-92. PubMed ID: 8102597
[TBL] [Abstract][Full Text] [Related]
8. Expression of N-acetyltransferase (NAT) in cultured human uroepithelial cells.
Kloth MT; Gee RL; Messing EM; Swaminathan S
Carcinogenesis; 1994 Dec; 15(12):2781-7. PubMed ID: 8001235
[TBL] [Abstract][Full Text] [Related]
9. Genotyping human arylamine N-acetyltransferase type 1 (NAT1): the identification of two novel allelic variants.
Payton MA; Sim E
Biochem Pharmacol; 1998 Feb; 55(3):361-6. PubMed ID: 9484803
[TBL] [Abstract][Full Text] [Related]
10. Acetylator genotype-dependent expression of arylamine N-acetyltransferase and N-hydroxyarylamine O-acetyltransferase in Syrian inbred hamster intestine and colon. Identity with the hepatic acetylation polymorphism.
Ogolla F; Ferguson RJ; Kirlin WG; Trinidad A; Andrews AF; Mpezo M; Hein DW
Drug Metab Dispos; 1990; 18(5):680-5. PubMed ID: 1981720
[TBL] [Abstract][Full Text] [Related]
11. Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype-genotype correlation with the sulfamethazine test.
Taja-Chayeb L; González-Fierro A; Miguez-Muñoz C; Trejo-Becerril C; Cruz-Hernandez Ede L; Cantu D; Agundez JA; Vidal-Millan S; Gutierrez O; Dueñas-González A
Pharmacogenet Genomics; 2011 Dec; 21(12):894-901. PubMed ID: 21946899
[TBL] [Abstract][Full Text] [Related]
12. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
Grant DM; Blum M; Beer M; Meyer UA
Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
[TBL] [Abstract][Full Text] [Related]
13. Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase.
Hein DW; Flammang TJ; Kirlin WG; Trinidad A; Ogolla F
Carcinogenesis; 1987 Dec; 8(12):1767-74. PubMed ID: 3677303
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the arylamine N-acetyltransferase polymorphism in a Spanish population.
Agúndez JA; Martínez C; Olivera M; Ledesma MC; Ladero JM; Benítez J
Clin Pharmacol Ther; 1994 Aug; 56(2):202-9. PubMed ID: 8062497
[TBL] [Abstract][Full Text] [Related]
15. Identification and functional characterization of novel polymorphisms associated with the genes for arylamine N-acetyltransferases in mice.
Boukouvala S; Price N; Sim E
Pharmacogenetics; 2002 Jul; 12(5):385-94. PubMed ID: 12142728
[TBL] [Abstract][Full Text] [Related]
16. Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations.
Deloménie C; Sica L; Grant DM; Krishnamoorthy R; Dupret JM
Pharmacogenetics; 1996 Apr; 6(2):177-85. PubMed ID: 9156695
[TBL] [Abstract][Full Text] [Related]
17. Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.
Hein DW; Doll MA
Arch Toxicol; 2017 Aug; 91(8):2827-2835. PubMed ID: 28523442
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the xenobiotic-metabolizing enzymes CYP1A1 and NAT-2 in systemic sclerosis and lupus erythematosus.
von Schmiedeberg S; Fritsche E; Rönnau AC; Specker C; Golka K; Richter-Hintz D; Schuppe HC; Lehmann P; Ruzicka T; Esser C; Abel J; Gleichmann E
Adv Exp Med Biol; 1999; 455():147-52. PubMed ID: 10599336
[TBL] [Abstract][Full Text] [Related]
19. Molecular genotyping of N-acetylation polymorphism to predict phenotype.
Mashimo M; Suzuki T; Abe M; Deguchi T
Hum Genet; 1992; 90(1-2):139-43. PubMed ID: 1427770
[TBL] [Abstract][Full Text] [Related]
20. Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations.
Butcher NJ; Ilett KF; Minchin RF
Pharmacogenetics; 1998 Feb; 8(1):67-72. PubMed ID: 9511183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
